Targeting Alpha5 Beta1 Integrin to Prevent Metastatic Breast Cancer Cell Invasion: PhScN Target Site Definition and Plasma Stability

reportActive / Technical Report | Accession Number: AD1001177 | Open PDF

Abstract:

We proposed to test PHSCN and PhScN derivatives with modifications of the N or Ctermini, andor cysteine side chain to determine the initial spatial constraints of the binding pocket of the ligand to its target site. This will aid in the selection of crosslinking agents, modifications, tag additions and strategies for determination of the target sites performed in Aim 2 and lay the foundation for determining the structure-activity relationships SARS of these inhibitors with the target

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release;

RECORD

Collection: TR
Subject Terms